Global research team aims to tackle tropical disease
A global research team is aiming to tackle schistosomiasis, a neglected tropical disease affecting millions worldwide.
Researchers at the University of Glasgow will lead a large international collaboration with partners from Cameroon, Côte D’Ivoire, Malawi and the UK to better understand why schistosomiasis remains a devastating disease in many parts of Africa, despite more than two decades of mass drug administration.
The DRIVERS project, which has been awarded £8.1 million ($10.9 million) funding from Wellcome, aims to identify the causes of schistosomiasis treatment failure and find evidence-based recommendations to improve disease control.
Schistosomiasis, a neglected tropical disease caused by parasitic worms, affects more than 240 million people worldwide, with the majority living in sub-Saharan Africa. Transmission is most common in impoverished areas where access to clean water and sanitation is limited forcing communities to use water infected with the parasites for everyday use.
The disease has severe health consequences, particularly for children, including anaemia, stunted growth, and impaired cognitive development. Long term schistosomiasis infection can lead to organ damage, including liver and kidney failure, and bladder cancer and cause severe reproductive issues and pain. Despite extensive efforts to combat schistosomiasis, the disease remains entrenched in many regions.
Professor Poppy Lamberton, Study Lead from the University of Glasgow, said: “I am excited to be working with global experts to really tease out why drug treatment is not effective in some people, and why certain communities continue to have such high transmission despite repeated mass drug treatments. Findings will be rapidly shared with other affected countries and colleagues at the World Health Organization, to provide evidence-based recommendations to help us move towards eliminating this debilitating disease as a public health problem.”
The DRIVERS project will bring schistosomiasis experts together, including researchers in field epidemiology, immunology, genetics and mathematical modelling, schistosomiasis control programme managers and regional health ministries. Together, they will investigate causes of poor treatment outcomes at both individual and community levels across diverse settings.
The DRIVERS project includes researchers at the Centre Suisse de Recherches Scientifiques in Côte d’Ivoire, Kamuzu University of Health Sciences and Malawi Liverpool Wellcome Research Programme in Malawi, Institute of Medical Research and Medicinal Plant Studies in Cameroon, and University of Glasgow, University of Surrey, London School of Hygiene and Tropical Medicine, University of Dundee and UnlimitHealth in the UK in collaboration with policy makers and Ministry of Health partners.
Bruno Quinney, Content Team, DDW
